Immunisation+3
RecruitingSARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
SARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
- Disease:ImmunisationInfluenza immunisation+2
- Substances:TAK-019INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED+5
Portugal- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:TAK-019
- Sponsor:Sanofi Vaccines US Inc.








